This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Company Filing History:
1 out of 834,411 Years Active: 2002
Title: Bennett Curtis Burke - Innovator in Eye Movement Disorder Treatment
Introduction
Bennett Curtis Burke is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of medical devices, particularly in the treatment of eye movement disorders. His innovative approach has the potential to improve the quality of life for individuals suffering from these conditions.
Latest Patents
Bennett Curtis Burke holds a patent for an "Acquired Pendular Nystagmus Treatment Device." This device is designed to treat eye movement disorders in a non-invasive and non-pharmacologic manner. It is wearable and utilizes servo-controlled prisms to address disorders of ocular mobility. The device features an eye movement sensor and oscillates the image perceived by the patient in sync with pathological nystagmus, effectively negating its harmful effects. Importantly, the device only targets abnormal eye movements, allowing voluntary and normal reflex eye movements to function without interference. In addition to acquired pendular nystagmus (APN), the device may also be applicable for treating non-sinusoidal ocular oscillations, strabismus, vestibular insufficiency, and other ocular mobility disorders.
Career Highlights
Bennett Curtis Burke's career is marked by his dedication to advancing medical technology. His innovative patent reflects his commitment to finding effective solutions for complex health issues. His work has the potential to revolutionize the treatment of eye movement disorders, providing patients with new hope and improved outcomes.
Collaborations
Bennett has collaborated with notable professionals in his field, including John S Stahl and Mark J Lehmkuhle. These partnerships have likely contributed to the development and refinement of his innovative device.
Conclusion
Bennett Curtis Burke is a pioneering inventor whose work in developing a treatment device for eye movement disorders showcases his commitment to innovation in healthcare. His contributions have the potential to significantly impact the lives of those affected by these conditions.